Clinical Trials Logo

Esophageal and Gastric Varices clinical trials

View clinical trials related to Esophageal and Gastric Varices.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05979935 Active, not recruiting - Clinical trials for Esophageal and Gastric Varices

Prediction of Esophageal Varices in Liver Cirrhosis Using Tongue Bioinformatics

Start date: July 1, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to compare the tongue bioinformatics of high-risk and low-risk patients with esophageal varices due to liver cirrhosis. The main question of this study is to explore whether there exists a relationship between the degree of esophageal varices and tongue bioinformatics in liver cirrhosis. it aims to answer 2 questions as below: question 1: If these is a significant difference in tongue bioinformatics between patients in liver cirrhosis with high-risk and low-risk of esophageal varices. Question 2; If tongue bioinformatics can be used as a diagnostic basic for testing esophageal varices in liver cirrhosis. Firstly, participants will be divided into two groups according to their degree of esophageal varices from electronic gastroscopy report and CT scan report including high-risk group and low-risk group. Secondly, participants will be asked to show their tongue, including the surface and sublingual veins of tongue, and the tongue images of each participants will be collected by researchers via camera. After finishing tongue image collection, participants will receive a professional tongue diagnosis report in Traditional Chinese Medicine and health suggestion.

NCT ID: NCT04365868 Active, not recruiting - Cirrhosis Clinical Trials

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

NAVIGATE
Start date: June 22, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability of belapectin compared with placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis and clinical signs of portal hypertension but without esophageal varices at baseline.

NCT ID: NCT03736265 Active, not recruiting - Portal Hypertension Clinical Trials

Carvedilol for Prevention of Esophageal Varices Progression

Carvedilol
Start date: October 9, 2017
Phase: N/A
Study type: Interventional

Carvedilol has been shown to be more potent in decreasing portal hypertension to propranolol. But the efficacy of carvedilol to delay the growth of esophageal varices in chronic hepatitis B patients was unclear.

NCT ID: NCT03705078 Active, not recruiting - Cirrhosis Clinical Trials

"Early TIPS" Versus Glue Obliteration to Prevent Rebleeding From Gastric Varices

GAVAPROSEC
Start date: January 3, 2019
Phase: N/A
Study type: Interventional

The primary objective of the study is to demonstrate the superiority of an "early tips" strategy over standard treatment by glue obliteration (G0) in preventing bleeding recurrence or death at one year after a non GOV1 gastric variceal bleeding in cirrhotic patients initially treated by GO.

NCT ID: NCT03388125 Active, not recruiting - Clinical trials for Bleeding Esophageal Varices

Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection

Start date: January 1, 2016
Phase: Phase 3
Study type: Interventional

Endoscopic Injection Sclerotherapy vs N-butyl-2-cyanoacrylate Injection

NCT ID: NCT03045783 Active, not recruiting - Cirrhosis Clinical Trials

Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices

PUoA-EIoTA
Start date: December 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of prophylactic use of antibiotics in endoscopic injection of tissue adhesive in gastric varices.